Chemo Drug Taxotere Linked to Permanent Hair Loss in Women

Chemo Drug Taxotere Linked to Permanent Hair Loss in Women

Taxotere hair loss
Contact us following Taxotere hair loss to see what your options are.

Our lawyers at Mike Brandner Injury Attorneys are now reviewing potential lawsuits for women who suffered permanent hair loss, alopecia or baldness after receiving the chemotherapy drug Taxotere intravenously to treat breast cancer. Potential lawsuits may entitle breast cancer patients compensation for pain, suffering and other damages. Please contact us today for a free case review.

What is Taxotere?

Taxotere is a chemotherapy drug made by Sanofi-Aventis and is used to treat breast cancer. The drug works by interfering with the growth and spread of cancer cells in the body. Many women have suffered Taxotere hair loss.

More women were open to the chemo drug Taxotere because prescribed treatments were only required once every three weeks, as opposed to once a week with other similar drugs.

Why Women File Taxotere Lawsuits

Taxotere was first approved by the U.S. Food & Drug Administration (FDA) in 1996. In December 2015, the FDA acknowledged reports that linked chemotherapy patients treated with the drug to disfiguring permanent hair loss and also, baldness.

Although most women who undergo chemotherapy know that temporary hair loss is a common side effect, they also expect that their hair will start to grow back after six month.

Pending lawsuits allege that Sanofi marketed Taxotere as a superior drug to similar chemo treatments; despite knowing the potential high risk of permanent hair loss, baldness and alopecia in breast cancer patients.

The manufacturer also faces allegations to have ultimately misled the public and medical community; which increased the physical and emotional losses breast cancer survivors may experience after treatment. This may include negative body image, decreased quality of life and also severe depression.

Free Confidential Taxotere Hair Loss Lawsuit Evaluations

Thousands of women needlessly exposed themselves to the high risk of permanent hair loss and also baldness linked to Taxotere. Many women said that if they had received warnings of the risk for permanent alopecia, they would have chosen an alternate chemo drug.

Suffered permanent hair loss, balding or alopecia after chemo treatment with Taxotere? You may receive compensation by filing a lawsuit against Sanofi Aventis. Our class action lawsuit attorneys at Mike Brandner Injury Attorneys are currently reviewing cases involving Taxotere hair loss. So, contact us today!


Best of New OrleanBrandner Law Firm Better Business BureauBrandner Law Firm AvvoSuper Lawyers Michael BrandnerMichael Brandner Million Dollar Advocates ForumBest Personal Injury Attorneys in New Orleans The National Trial Lawyers Top 100